Abstract

Montelukast in the treatment of asthma and allergic rhinitis

Author(s): Helen Neighbour1, Andrew McIvor

Asthma and allergic rhinitis are common diseases that impact a large number
of people worldwide. Safe and effective treatments are needed to reduce the morbidity and,
in asthma, the mortality associated with them. In this article, we review the use of a leukotriene
receptor antagonist, montelukast, in the treatment of these conditions. This article provides an
overview of the pharmacology of montelukast and the guidline recommendations for its use in
asthma and allergic rhinitis.
 
 

 


PDF